Shares of AstraZeneca (AZN) are lower as more headlines emerge on the scope of the ongoing China probe of the company’s China president, ...
The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is ...